[1] U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogeneelaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B.Retrieved April 26, 2024 from https://www.pfizer.com/news/press-release/press-release-detail/us-fda-approves-pfizers-beqveztm-fidanacogene-elaparvovec